SEO_list_Champion Electronics Technology Co., Ltd.

Hotline: 86-27-84888155

OA / E-mail / Download / 中文版

SEO Tag List

home page > SEO tag > Medical equipment

No content information display available

Medical equipment

Product content

Medtronic cryoablation instrument

cryoablation device Cardiac cryoablation system Product Manual The cryoablation instrument consists of electronic and mechanical components and patented software for manipulating and recording the Arctic Front® cryoballoon catheter or Freezor® cryoablation catheter for cryotherapy procedures. Its stored liquid cryogen can be delivered to the ablation catheter via a coaxial connection cable. After ablation, the endothermic vaporized cryogen is finally discharged through the hospital ventilation system. Medtronic cryoablation devices and cryoablation catheters have a variety of features to significantly improve safety. Ordering Information Order No. 160E2 For use with the Arctic Front Cryoballoon Catheter or Freezor Cryoablation Catheter

Medical equipment
Fresenius Kabi Syringe Pump, Infusion Pump

Registration certificate number: INfusia VP7/VP7s Hunan Machinery Note 20152540019 INfusia VP7/VP7s Hunan Machinery Note 20152540020

Medical equipment
blood sugar needle 2

Technical parameters of Omnican® Berry® disposable injection pen Main technical parameters Detailed description Scope of use: Universal compatibility, suitable for various insulin injection pens, growth hormone/progestin injection pens, etc. Suitable for subcutaneous drug injection Product specifications 4mm, 6mm 31G; 4mm, 5mm, 6mm 32G Packaging features 7 packs/100 packs, green transparent inner cap design, easy to observe the exhaust Product material Injection needle: 304 stainless steel, lubricant (DOW CORNING® MDX4-4159 50% medical silicone oil main component: dimethoxysilylethylenediaminopropylpolydimethylsiloxane) Connection device: Polyethylene (PE) Needle protection inner cap: styrene-butadiene copolymer (SB) Outer protective cap: polyethylene (PE) No DEHP (phthalate), no plasticizers such as BPA (bisphenol A) Needle wall technology According to ISO 9626 standard: 32G 4/5/6MM needle outer diameter: 0.24+0.001/-0.001, needle inner diameter: 0.156+0.010/-0.010, needle length: 4/5/6+1.25/-0 31G 4/5/6MM needle outer diameter: 0.26+0.007/-0.006, needle inner diameter: 0.146+0.014/-0, needle length: 4/5/6+1.25/-0 The ultra-thin-walled and large-lumen design of the needle tube ensures fast injection flow without delay Sterilization method Ethylene oxide sterilization (residue <10μg/g) Silicone Oil Technology: Compliant with ISO 7864, surface coating not exceeding 0.25mg/cm², no residue of silicone grease Compliant with marking EC Certificate Full Quality Assurance System No.G1180412974455

Medical equipment
Braun infusion management system

Advanced ICU Infusion Therapy Solutions Make your infusion therapy manageable The quality is more guaranteed more economical Beth TM B.Braun Space Infusion therapy management system

Medical equipment
Fresenius Kabi Syringe Pump, Infusion Pump

Registration certificate number: INfusia VP7/VP7s Hunan Machinery Note 20152540019 INfusia VP7/VP7s Hunan Machinery Note 20152540020

Medical equipment
blood sugar needle 2

Technical parameters of Omnican® Berry® disposable injection pen Main technical parameters Detailed description Scope of use: Universal compatibility, suitable for various insulin injection pens, growth hormone/progestin injection pens, etc. Suitable for subcutaneous drug injection Product specifications 4mm, 6mm 31G; 4mm, 5mm, 6mm 32G Packaging features 7 packs/100 packs, green transparent inner cap design, easy to observe the exhaust Product material Injection needle: 304 stainless steel, lubricant (DOW CORNING® MDX4-4159 50% medical silicone oil main component: dimethoxysilylethylenediaminopropylpolydimethylsiloxane) Connection device: Polyethylene (PE) Needle protection inner cap: styrene-butadiene copolymer (SB) Outer protective cap: polyethylene (PE) No DEHP (phthalate), no plasticizers such as BPA (bisphenol A) Needle wall technology According to ISO 9626 standard: 32G 4/5/6MM needle outer diameter: 0.24+0.001/-0.001, needle inner diameter: 0.156+0.010/-0.010, needle length: 4/5/6+1.25/-0 31G 4/5/6MM needle outer diameter: 0.26+0.007/-0.006, needle inner diameter: 0.146+0.014/-0, needle length: 4/5/6+1.25/-0 The ultra-thin-walled and large-lumen design of the needle tube ensures fast injection flow without delay Sterilization method Ethylene oxide sterilization (residue <10μg/g) Silicone Oil Technology: Compliant with ISO 7864, surface coating not exceeding 0.25mg/cm², no residue of silicone grease Compliant with marking EC Certificate Full Quality Assurance System No.G1180412974455

Medical equipment

News content

Sinopharm Instruments and Dongfang Biotech signed a strategic cooperation agreement

On March 25, 2022, China Medical Devices Co., Ltd. (hereinafter referred to as "Sinopharm Instrument") and Zhejiang Dongfang Gene Biological Products Co., Ltd. (hereinafter referred to as "Dongfang Bio") signed a strategic cooperation agreement in the form of an online contract. Zhang Wei, deputy general manager of Sinopharm Instruments, and Xu Faying, deputy general manager of Oriental Biological Sales, signed the contract on behalf of both parties. He Tao, President of Zhejiang Medical Device Industry Association, Li Jianfei, Assistant General Manager of Sinopharm, Hu Zhenyu, Deputy General Manager of the Western Division, Hu Pan, Director of Marketing, Yan Jipeng, Deputy Director, Zhao Hui, Executive Deputy General Manager and Deputy General Manager of Sinopharm Zhejiang Company Zhao Liang and Zhan Yao, Director of the General Manager's Office of Oriental Biology, attended the ceremony and witnessed the signing ceremony. Oriental Bio was established in 2005 and listed on the Shanghai Stock Exchange's Science and Technology Innovation Board in 2020. It is an enterprise specializing in the production, sales and research of IVD in vitro diagnostic products. Its business fields cover molecular diagnostic platforms, POCT rapid diagnostic platforms, and liquid biochip platforms. On March 15, 2022, it became the first medical device enterprise in Zhejiang Province to obtain the registration certificate for the domestic novel coronavirus antigen detection kit. Deputy General Manager Zhang Wei pointed out in the signing speech that with the signing of this strategic cooperation agreement, Sinopharm will give full play to the advantages of integrated marketing, and rely on the national network layout and logistics and information resources to deepen cooperation with Orient Bio in various aspects. Cooperation. At the same time, Sinopharm Instruments, as a national strategic reserve enterprise for medical devices, will jointly support the domestic new crown epidemic prevention and control needs through cooperation with Orient Bio in the new crown antigen detection kit. Deputy General Manager Xu Faying also expressed his willingness to share resources with Sinopharm and form a joint development force. President He Tao congratulated the two sides on the strategic cooperation and hoped that the two sides would make new contributions during the special period of epidemic prevention and control. In the future, Sinopharm Instruments and Orient Bio will build a nationwide professional supply chain channel to provide a full range of high-quality services for downstream distributors, terminal hospitals and more people.

Medical equipment
Sinopharm Group held a video conference on safety production to deploy a comprehensive inspection of safety production

On April 2, Sinopharm Group held a video conference on production safety, to study and implement the important instructions of General Secretary Xi Jinping on production safety and the spirit of Premier Li Keqiang's important instructions, and to implement the requirements of the national video conference on production safety and the video conference on production safety of central enterprises. Further strengthen the concept of "people first, life first", and redeploy, promote and implement the safety production work of the whole group. Liu Jingzhen, Secretary of the Party Committee, Chairman and Director of the Safety Committee of Sinopharm Group, attended the meeting and delivered a speech. Hu Jianwei, Deputy General Manager (in charge of business operations) and Deputy Director of the Safety Committee, presided over the meeting, and Dong Zenghe, Deputy General Manager and Deputy Director of the Safety Committee, conveyed the national safety The spirit of production video conference and video conference of central enterprise safety production work. The meeting pointed out that it is necessary to resolutely implement the important instructions of General Secretary Xi Jinping and the spirit of Premier Li Keqiang's instructions, adhere to the overall development and safety, deeply understand the extreme importance of doing a good job in safety production, put safety production in a more prominent position, and be strict and meticulous. Do a good job in safety production. It is necessary to earnestly learn the lessons of recent accidents, draw inferences from one case to another, comprehensively investigate the implementation of safety responsibilities, safety risk prevention, hidden danger investigation and management, professional team building, rules and regulations implementation, safety assurance capabilities and other aspects, and earnestly do a good job of stabilizing growth, ensuring safety, and preventing risks. Work. The meeting called for coordinating economic development, epidemic prevention and control, and work safety, comprehensively promoting ideological understanding and further improving, comprehensively pressing and consolidating work safety responsibilities, comprehensively and solidly carrying out work safety inspections, and comprehensively promoting special rectification in key areas. Consolidate the foundation of safety management, resolutely prevent the occurrence of various production safety accidents, and create a safe and stable environment for the successful holding of the 20th National Congress of the Communist Party of China. All employees of Sinopharm Group Safety Committee, Safety Committee Office and Headquarters attended the meeting in the main venue, while the safety committees and middle-level managers of subordinate enterprises at all levels attended the meeting by video in the branch venues.

Medical equipment